Vineti is a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies. This company was founded by Razmik Abnous, Amy DuRoss, Malek Faham, Heidi Hagen, Stephen Ting in 2016 and is headquartered in San Francisco, CA. Vineti's software solution Personalized Therapy Management (patent pending) automates patient-centric supply chains for a wide range of advanced therapies, in all phases of clinical development and commercial operations.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
10/13/2020 | Series C-2 | $94,476 | $xx.xx | $216.51MM | Cardinal Health, Marc Benioff, Canaan Partners, Threshold Ventures, Section 32, Casdin Capital, Novartis Pharma AG, McKesson Ventures, LifeForce Capital, Hive Ventures | |
Price per Share
$xx.xx
Shares Outstanding
9,447,595
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Cardinal Health, Marc Benioff, Canaan Partners, Threshold Ventures, Section 32, Casdin Capital, Novartis Pharma AG, McKesson Ventures, LifeForce Capital, Hive Ventures
|
||||||
10/13/2020 | Series C-1 | $31,162 | $xx.xx | $216.51MM | Cardinal Health, Marc Benioff, Canaan Partners, Threshold Ventures, Section 32, Casdin Capital, Novartis Pharma AG, McKesson Ventures, LifeForce Capital, Hive Ventures | |
Price per Share
$xx.xx
Shares Outstanding
3,116,232
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Cardinal Health, Marc Benioff, Canaan Partners, Threshold Ventures, Section 32, Casdin Capital, Novartis Pharma AG, McKesson Ventures, LifeForce Capital, Hive Ventures
|
||||||
10/13/2020 | Series C | $60MM | $xx.xx | $216.51MM | Cardinal Health, Marc Benioff, Canaan Partners, Threshold Ventures, Section 32, Casdin Capital, Novartis Pharma AG, McKesson Ventures, LifeForce Capital, Hive Ventures | |
Price per Share
$xx.xx
Shares Outstanding
35,947,511
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Cardinal Health, Marc Benioff, Canaan Partners, Threshold Ventures, Section 32, Casdin Capital, Novartis Pharma AG, McKesson Ventures, LifeForce Capital, Hive Ventures
|
||||||
04/16/2018 | Series B | $33.5MM | $xx.xx | $48.7MM | Canaan Partners, Threshold Venturess, GE Ventures, Section 32, Casdin Capital, LifeForce Capital | |
Price per Share
$xx.xx
Shares Outstanding
33,070,086
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Canaan Partners, Threshold Venturess, GE Ventures, Section 32, Casdin Capital, LifeForce Capital
|
||||||
06/22/2017 | Series A | $14.09MM | $xx.xx | $28.18MM | GE Ventures, Mayo Clinic Ventures, Threshold Ventures, LifeForce Capital | |
Price per Share
$xx.xx
Shares Outstanding
5,123,423
Liquidation Pref Order
1
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
2.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
GE Ventures, Mayo Clinic Ventures, Threshold Ventures, LifeForce Capital
|